Great explanation KBC. There may be one very small little twist though. I believe the wholly-owned subsidiary is Zenith Epigenetics Ltd commonly referred to in corporate presentations as ZEL.

Question; if ZCC sells ZEL does there need to be a special meeting and a shareholder vote before a deal can be consummated? My thought is no, as it would be normal course business of ZCC to sell a subsidiary. What do others think?

tada